Literature DB >> 29425105

IL8 and IL16 levels indicate serum and plasma quality.

Olga Kofanova1, Estelle Henry1, Rocio Aguilar Quesada2, Alexandre Bulla3, Hector Navarro Linares2, Pierre Lescuyer3, Kathi Shea4, Mars Stone5, Gunnel Tybring6, Camille Bellora1, Fay Betsou1.   

Abstract

BACKGROUND: Longer pre-centrifugation times alter the quality of serum and plasma samples. Markers for such delays in sample processing and hence for the sample quality, have been identified.
METHODS: Twenty cytokines in serum, EDTA plasma and citrate plasma samples were screened for changes in concentration induced by extended blood pre-centrifugation delays at room temperature. The two cytokines that showed the largest changes were further validated for their "diagnostic performance" in identifying serum or plasma samples with extended pre-centrifugation times.
RESULTS: In this study, using R&D Systems ELISA kits, EDTA plasma samples and serum samples with a pre-centrifugation delay longer than 24 h had an IL16 concentration higher than 313 pg/mL, and an IL8 concentration higher than 125 pg/mL, respectively. EDTA plasma samples with a pre-centrifugation delay longer than 48 h had an IL16 concentration higher than 897 pg/mL, citrate plasma samples had an IL8 concentration higher than 21.5 pg/mL and serum samples had an IL8 concentration higher than 528 pg/mL.
CONCLUSIONS: These robust and accurate tools, based on simple and commercially available ELISA assays can greatly facilitate qualification of serum and plasma legacy collections with undocumented pre-analytics.

Entities:  

Keywords:  interleukin; plasma; preanalytical; quality control; serum

Mesh:

Substances:

Year:  2018        PMID: 29425105     DOI: 10.1515/cclm-2017-1047

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  2 in total

Review 1.  Genetics meets proteomics: perspectives for large population-based studies.

Authors:  Karsten Suhre; Mark I McCarthy; Jochen M Schwenk
Journal:  Nat Rev Genet       Date:  2020-08-28       Impact factor: 53.242

2.  The CONSTANCES Cohort Biobank: An Open Tool for Research in Epidemiology and Prevention of Diseases.

Authors:  J Henny; R Nadif; S Le Got; S Lemonnier; A Ozguler; F Ruiz; K Beaumont; D Brault; E Sandt; M Goldberg; M Zins
Journal:  Front Public Health       Date:  2020-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.